These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34058101)

  • 1. Changes in Dialysis Center Quality Associated With the End-Stage Renal Disease Quality Incentive Program : An Observational Study With a Regression Discontinuity Design.
    Sheetz KH; Gerhardinger L; Ryan AM; Waits SA
    Ann Intern Med; 2021 Aug; 174(8):1058-1064. PubMed ID: 34058101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States.
    Ajmal F; Probst JC; Brooks JM; Hardin JW; Qureshi Z; Jafar TH
    Am J Kidney Dis; 2020 Feb; 75(2):177-186. PubMed ID: 31685294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role Of Social Risk Factors In Dialysis Facility Ratings And Penalties Under A Medicare Quality Incentive Program.
    Qi AC; Butler AM; Joynt Maddox KE
    Health Aff (Millwood); 2019 Jul; 38(7):1101-1109. PubMed ID: 31260369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Ajmal F; Probst J; Brooks J; Hardin J; Qureshi Z
    Am J Nephrol; 2019; 49(1):64-73. PubMed ID: 30557871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital Characteristics Associated With Penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program.
    Rajaram R; Chung JW; Kinnier CV; Barnard C; Mohanty S; Pavey ES; McHugh MC; Bilimoria KY
    JAMA; 2015 Jul; 314(4):375-83. PubMed ID: 26219055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early winners and losers in dialysis center pay-for-performance.
    Saunders MR; Lee H; Chin MH
    BMC Health Serv Res; 2017 Dec; 17(1):816. PubMed ID: 29216894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social Risk and Dialysis Facility Performance in the First Year of the ESRD Treatment Choices Model.
    Koukounas KG; Thorsness R; Patzer RE; Wilk AS; Drewry KM; Mehrotra R; Rivera-Hernandez M; Meyers DJ; Kim D; Trivedi AN
    JAMA; 2024 Jan; 331(2):124-131. PubMed ID: 38193961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Dialysis Facility Quality and Facility Characteristics, Neighborhood Demographics, and Region.
    Zhang Y
    Am J Med Qual; 2016 Jul; 31(4):358-63. PubMed ID: 25838553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How the ESRD quality incentive program could potentially improve quality of life for patients on dialysis.
    Moss AH; Davison SN
    Clin J Am Soc Nephrol; 2015 May; 10(5):888-93. PubMed ID: 25739850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical director and quality requirements in the dialysis facility.
    Schiller B
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):493-9. PubMed ID: 25376762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafiltration Rates and the Quality Incentive Program: Proposed Measure Definitions and Their Potential Dialysis Facility Implications.
    Flythe JE; Assimon MM; Wenger JB; Wang L
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1422-1433. PubMed ID: 27335126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ESRD Quality Incentive Program-Can We Bridge the Chasm?
    Weiner D; Watnick S
    J Am Soc Nephrol; 2017 Jun; 28(6):1697-1706. PubMed ID: 28298324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the consumer assessment of healthcare providers and systems in-center hemodialysis survey.
    Wood R; Paoli CJ; Hays RD; Taylor-Stokes G; Piercy J; Gitlin M
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1099-108. PubMed ID: 24832092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System.
    Brady BM; Zhao B; Niu J; Winkelmayer WC; Milstein A; Chertow GM; Erickson KF
    JAMA Intern Med; 2018 Oct; 178(10):1358-1367. PubMed ID: 30208398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing dialysis facility-specific performance measures for public reporting.
    Frederick PR; Maxey NL; Clauser SB; Sugarman JR
    Health Care Financ Rev; 2002; 23(4):37-50. PubMed ID: 12500469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting the 2012 QIP (Quality Incentive Program) clinical measures: strategies for dialysis centers.
    Fishbane S; Hazzan A
    Am J Kidney Dis; 2012 Nov; 60(5 Suppl 1):S5-13; quiz S14-7. PubMed ID: 23063058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring quality of care at dialysis facilities: a case for regulatory parsimony--and beyond.
    Stivelman JC
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1673-81. PubMed ID: 22822012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The QIP: will it improve dialysis care? An overview.
    Fishbane S; Miller I; Danko H; Masani N
    Nephrol News Issues; 2012 Jan; 26(1):20, 22-4, 26. PubMed ID: 22359961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes to the end-stage renal disease quality incentive program.
    Fishbane S; Miller I; Wagner JD; Masani NN
    Kidney Int; 2012 Jun; 81(12):1167-71. PubMed ID: 22534963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in dialysis quality measures by facility, neighborhood, and region.
    Saunders MR; Chin MH
    Med Care; 2013 May; 51(5):413-7. PubMed ID: 23579351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.